| Document Date: 2014-10-07 00:24:52
Open Document File Size: 311,45 KBShare Result on Facebook
Company GlaxoSmithKline / / IndustryTerm dairy products / / MedicalCondition chronic liver disease undergoing / abdominal pain / insomnia / antiphospholipid syndrome / influenza-like illness / Cataracts / headache / WARNINGS AND PRECAUTIONS Hepatic Decompensation / chronic liver disease receiving PROMACTA / chills / chronic liver disease / Carcinogenesis / Portal vein thrombosis / Chronic ITP PROMACTA / nausea / Chronic Hepatitis C-associated Thrombocytopenia / Severe Aplastic Anemia / thrombocytopenia / thromboembolism / alopecia / ATIII deficiency / Infection PROMACTA / pain / vomiting / fatigue / portal venous thrombosis / encephalopathy / myalgia / urinary tract infection / Chronic ITP / diarrhea / infection / increased ALT / liver injury / cough / End-Stage Liver Disease / Severe Aplastic Anemia PROMACTA / pruritus / rash / back pain / influenza / hepatic decompensation / paresthesia / pharyngitis / anemia / chronic hepatitis C / Immune (Idiopathic) Thrombocytopenia / upper respiratory tract infection / thrombocytopenia and clinical condition / / MedicalTreatment immunosuppressive therapy / invasive procedures / antiviral therapy / / Organization DOSAGE AND ADMINISTRATION / FDA / / / Position Major / / Product GS / ribavirin / Peginterferon / / Technology Pharmacokinetics / / URL www.fda.gov/medwatch / /
SocialTag |
• HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA.